Subject: Taro: Is it really a winner?

See what's new on our blog | View this email in your Browser
 
           
 
 
TARO: Is It Really A Winner?
Taro Logo
We plucked Taro Pharmaceuticals (TARO) out of the stock universe via a mid cap quant screener. It then went on to handily win every round of our ‘March Midness’ mid cap stock tournament, from Growth to Valuation. But is it really a company you would want to invest in? Now, without the conceit of the tournament, we took a closer look at TARO to determine if the company really has game...
 
Read the Full Article
 
 
 
Have You Tried the New UI?
 
The Quotes Box, Portfolio Rebalancing, a handy new Start Menu, and much more—these are just a few of the changes we brought on with last month's release of Stock Rover 6.0. Be sure to take advantage of all the great new stuff!
 
 
See What's New
 
 
 
Featured Webinar: March Midness Finals
March Midness
 

Yes, it has been quiet on the webinar front, as we at Stock Rover offices have been busily working on some exciting behind-the-scenes stuff. So it's a great time to catch up on the webinars you missed! Today, in honor of the TARO blog post, we're featuring our March Midness wrap-up, so you can see how we found and whittled down a list of 32 mid cap stocks.

Click the button below to watch, or check out our Video Library to peruse all of our recorded webinars and short tutorial videos.
 
Watch the Webinar
 
 
 
 
Thank you for your interest in Stock Rover. We wish you a peaceful and enjoyable Memorial Day weekend.


Sincerely,

The Stock Rover Team

www.stockrover.com

Videos & Webinars Send Feedback
Blog Articles Getting Started
Stock Rover Mobile Discover Premium
 
Change your email preferences by logging into Stock Rover and going to Email Notifications in the top right-hand menu